» Articles » PMID: 34659133

Effects of and Variants on Hormonal Profile and Reproductive Outcomes of Infertile Women With Endometriosis

Overview
Specialty Endocrinology
Date 2021 Oct 18
PMID 34659133
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Single nucleotide variants (SNVs) :c.-211G>T, :c.919G>A, and :c.2039G>A were reported to be associated with the variability in FSH and LH levels, and fertilization (IVF) outcomes. In this study, we aimed to evaluate the effects of :c.-211G>T, :c.919G>A, and c.2039G>A variants, alone and combined, on the hormonal profile and reproduction outcomes of women with endometriosis.

Methods: A cross-sectional study was performed comprising 213 infertile Brazilian women with endometriosis who underwent IVF treatment. Genotyping was performed using TaqMan real-time PCR. Variables were compared according to the genotypes of each variant and genetic models, and the combined effects of the SNVs were evaluated using the multifactorial dimensionality reduction method.

Results: :c.-211G>T affected LH levels in women with overall endometriosis and minimal/mild disease. :c.919G>A affected FSH levels in women with overall endometriosis and the number of oocytes retrieved in those with moderate/severe endometriosis. Moreover, the :c.2039G>A affected FSH levels in women with overall endometriosis, LH levels and total amount of rFSH in those with minimal/mild disease, and number of follicles and number of oocytes retrieved in those with moderate/severe endometriosis. No effect on hormone profile or reproductive outcomes was observed when the genotypes were combined.

Conclusions: Variants of the and genes separately interfered with the hormonal profiles and IVF outcomes of women with endometriosis.

Citing Articles

Endometrial expression of ERRβ and ERRγ: prognostic significance and clinical correlations in severe endometriosis.

Wang Z, Guo S, Xie Y, Tong Y, Qi W, Wang Z Front Endocrinol (Lausanne). 2024; 15:1489097.

PMID: 39678195 PMC: 11637862. DOI: 10.3389/fendo.2024.1489097.


Proteome-wide Mendelian randomization provides novel insights into the pathogenesis and druggable targets of osteoporosis.

Yan J, Huai Y, Liang Q, Lin L, Liao B Front Med (Lausanne). 2024; 11:1426261.

PMID: 39526243 PMC: 11543481. DOI: 10.3389/fmed.2024.1426261.


Significance of and gene polymorphisms on clinical outcomes in gonadotropin-releasing hormone antagonist protocol with freeze-all strategy: A case-control study.

Amin J, Sandhya Alle N, Patel A, Prajapathi B, Makwana P, Prakash J Int J Reprod Biomed. 2024; 22(7):539-552.

PMID: 39355311 PMC: 11441282. DOI: 10.18502/ijrm.v22i7.16962.


Oocyte Cryopreservation in Women with Ovarian Endometriosis.

Mifsud J, Pellegrini L, Cozzolino M J Clin Med. 2023; 12(21).

PMID: 37959232 PMC: 10649633. DOI: 10.3390/jcm12216767.


Implication of FSHB rs10835638 variant in endometriosis in Brazilian women.

Bianco B, Loureiro F, Trevisan C, Christofolini D, Lagana A, Barbosa C Einstein (Sao Paulo). 2023; 21:eAO0483.

PMID: 37909652 PMC: 10586852. DOI: 10.31744/einstein_journal/2023AO0483.


References
1.
Salzano F, Sans M . Interethnic admixture and the evolution of Latin American populations. Genet Mol Biol. 2014; 37(1 Suppl):151-70. PMC: 3983580. DOI: 10.1590/s1415-47572014000200003. View

2.
Tafazoli A, Wolczynski S, Wawrusiewicz-Kurylonek N, Esmaeili S, Miltyk W . Pharmacogenomic Biomarkers of Follicle-Stimulating Hormone Receptor Malfunction in Females with Impaired Ovarian Response-A Genetic Survey. J Clin Med. 2021; 10(2). PMC: 7825139. DOI: 10.3390/jcm10020170. View

3.
Simoni M, Casarini L . Mechanisms in endocrinology: Genetics of FSH action: a 2014-and-beyond view. Eur J Endocrinol. 2013; 170(3):R91-107. DOI: 10.1530/EJE-13-0624. View

4.
Calle M, Urrea V, Malats N, Van Steen K . mbmdr: an R package for exploring gene-gene interactions associated with binary or quantitative traits. Bioinformatics. 2010; 26(17):2198-9. DOI: 10.1093/bioinformatics/btq352. View

5.
Conforti A, Vaiarelli A, Cimadomo D, Bagnulo F, Peluso S, Carbone L . Pharmacogenetics of FSH Action in the Female. Front Endocrinol (Lausanne). 2019; 10:398. PMC: 6606727. DOI: 10.3389/fendo.2019.00398. View